Cancer Center study if vaccines can prevent lung cancer recurrence
WLWT highlighted a University of Cincinnati Cancer Center clinical trial exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.
"Cancer vaccines, vaccines to prevent cancer, have been kind of the holy grail. Can we design a vaccine to prevent cancer? That's not really quite what this trial is looking at," Jennifer Leddon, MD, Cancer Center physician researcher and assistant professor in UC's College of Medicine, told WLWT. "It's really more looking at can we prevent cancer recurrence in someone who's already had cancer? That's where the personalized comes in. They make the vaccine from your cancer. They figure out what are the vulnerabilities of your cancer that they can target."
The vaccines are developed from a patient's own surgically removed tumor. In combination with immunotherapy, doctors are seeking to train the body's immune system to fight off remaining cancer cells.
"I could absolutely envision a scenario where they use the information from this study to identify common tumor antigens that are shared across many patients," Leddon said. "Not just your individual but many patients, and design a preventative vaccine based off of that."
The trial is open for patients seeking additional treatment options for lung cancer. Patients who have localized Stage II-II B (N2) lung cancer and are candidates for surgery may qualify. Patients can call 513-585-UCCC for more information.
Read about a similar pancreatic cancer vaccine trial at the Cancer Center.
Featured image at top: KRAS-driven lung cancer cells. Created by Eric Snyder, 2015. Image used courtesy of the National Institutes of Health.
Stay connected with the Cancer Center
Interested in learning more about the University of Cincinnati Cancer Center? Keep up to date by signing up for communications and newsletters based on your specific interests. Sign up for Cancer Center communications.
Latest UC News
- UC chief digital officer named Info-Tech 2024 CIO award winnerInfo-Tech Research Group recently named UC Vice President & Chief Digital Officer Bharath Prabhakaran a 2024 CIO Award winner in the Large and Enterprise Organization Division.
- How to get rid of a stuffy nose fastFindings in the International Journal of General Medicine reveal that a stuffy nose can trigger fatigue, brain fog and sleep disruptions that seriously interfere with daily activities. Now a University of Cincinnati College of Medicine professor of otolaryngology is sharing how to get rid of a stuffy nose quickly and naturally.
- Lorain County prosecutor seeks to toss conviction for wrongfully convicted Ohio manAl Cleveland, Jr., a client of the Ohio Innocence Project at Cincinnati Law, is one step closer to exoneration. The Lorain County prosecutor has filed to throw out his conviction, making the end of his 25 year ordeal within reach.
- Withrow Pathway to Lindner program challenges, motivates studentsThree graduates of Cincinnati Public Schools’ Withrow University High School of Business credit the partnership between the school and the Carl H. Lindner College of Business for their enrollment in the college.
- B-O-L-O-G-N-A: The staying power of Oscar Mayer’s jingleFew commercials have the staying power of the Oscar Mayer bologna jingle, which still has a place in American culture 50 years after its debut. James Kellaris, a professor of marketing at the University of Cincinnati, explained to NPR’s All Things Considered why the advertisement was so successful.
- UC celebrates the Marian Spencer Scholarship Program with special induction ceremonyWLWT segment features a recent induction ceremony for students in UC's Marian Spencer Scholarship Program. The scholarship was first announced in fall 2021 and was made possible by a large donation by 1988 graduate Jim Goetz and university investment. The Spencer Scholarship is for high-achieving Cincinnati Public School graduates and includes full tuition, room and board, a service abroad trip to Tanzania and many more opportunities.
